Business Context and Reporting Period
This Form 8-K is a current report filed by TRxADE HEALTH, Inc. (noting a discrepancy with the provided metadata company name "Scienture Holdings, Inc.") on July 7, 2023. The registrant is incorporated in Delaware and its common stock (Ticker: MEDS) trades on The Nasdaq Stock Market LLC. The report addresses a specific regulatory event regarding listing compliance.
Key Financial Metrics
This filing is an "Other Events" report (Item 8.01) and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
The material change reported is the resolution of a prior listing deficiency:
- Regulatory Status: The Company received a Compliance Letter from Nasdaq confirming it has regained compliance with Listing Rule 5550(a)(2).
- Bid Price Requirement: The Company previously failed to maintain a minimum bid price of $1.00 per share (notified December 1, 2022) and was granted 180 days to cure the deficiency.
- Resolution: Nasdaq determined the closing bid price was at or above $1.00 for 10 consecutive business days (June 22, 2023, to July 6, 2023), closing the matter.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or discussion of future risks beyond the resolution of the specific bid price compliance issue. No unusual items or contingencies are disclosed in this report.
Investor Verification Checklist
- Verify the correct registrant name is TRxADE HEALTH, Inc. (MEDS), as the metadata provided "Scienture Holdings, Inc."
- Confirm the current stock price remains above the $1.00 threshold to avoid future delisting notices.
- Review the prior Form 8-K filed on December 1, 2022, for details on the initial non-compliance notice.
- Check subsequent filings for any new financial results or operational updates, as this 8-K contains none.